Integrin alpha-6 drives metabolic adaptation and breast cancer survival in leptomeningeal metastasis
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
June 15, 2026
End Date
May 31, 2031
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
June 15, 2026
End Date
May 31, 2031